Adjunct Faculty
Adjunct faculty typically have an academic or research appointment at another institution and contribute or collaborate with one or more School of Medicine faculty members or programs.
Adjunct rank detailsKatrin Preller
Assistant Professor Adjunct, PsychiatryAbout
Research
Publications
2025
Correction: Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology
Shinozuka K, Jerotic K, Mediano P, Zhao A, Preller K, Carhart-Harris R, Kringelbach M. Correction: Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology. Translational Psychiatry 2025, 15: 470. PMID: 41233360, PMCID: PMC12615698, DOI: 10.1038/s41398-025-03731-7.Peer-Reviewed Original ResearchMemory deficits of MDMA users are linked to cortical thinning related to 5-HT receptor densities
Coray R, Beliveau V, Zimmermann J, Preller K, Wunderli M, Baumgartner M, Seifritz E, Stock A, Beste C, Cole D, Quednow B. Memory deficits of MDMA users are linked to cortical thinning related to 5-HT receptor densities. Brain 2025, awaf391. PMID: 41123310, DOI: 10.1093/brain/awaf391.Peer-Reviewed Original ResearchGray matter volumeMDMA usersMatter volumeMemory deficitsMemory dysfunctionMDMA useVerbal long-term memoryRobust reductionReceptor densityReduction of gray matter volumeBrain gray matter structureVerbal memory dysfunctionStructural brain alterationsGray matter differencesVerbal memory performanceLong-term memoryShort-term recallLong-term recallMemory performance scoresGray matter structuresSerotonergic basisVerbal learningMemory performanceMnemonic functionsBrain alterationsVisual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases
Heller N, Barrett F, Buchborn T, Collerton D, Dupuis D, Halberstadt A, Jardri R, Noorani T, Preller K, Taylor J, Waters F, Winston B, Leptourgos P. Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases. Schizophrenia Bulletin 2025, 51: s273-s291. PMID: 41051875, PMCID: PMC12498954, DOI: 10.1093/schbul/sbaf068.Peer-Reviewed Original ResearchConceptsVisual hallucinationsSerotonergic psychedelicsNeural mechanismsCortical activation patternsSerotonin 2ACore symptomsCognitive neuroscienceNeuroimaging studiesSerotonergic modulationAssociation cortexCortical signatureLewy body diseaseHallucinatory episodesCortical functionHallucinationsNeuromodulatory mechanismsSensory cortexReceptor upregulationSystems neuroscienceComplex hallucinationsActivity patternsPsychedelicsBody diseaseCortexNeuroscienceThe emotional architecture of the psychedelic brain
Moujaes F, Rieser N, Belinger L, Herdener M, Zahid Z, Preller K. The emotional architecture of the psychedelic brain. Trends In Cognitive Sciences 2025, 29: 1007-1022. PMID: 40830011, DOI: 10.1016/j.tics.2025.07.006.Peer-Reviewed Original ResearchEffects of psychedelicsImpact of psychedelicsEmotional processingMood disordersEmotional empathySerotonergic psychedelicsPsychiatric conditionsEmotion management strategiesPsychedelicsNeuroplastic changesMoodEmotional statesTemporal dynamicsEmotionsMechanism of actionComplex pictureTherapeutic impactEmotional architectureEmpathyDisordersBrainTherapeutic potentialClinical studiesTreatment approaches and efficacy in psychedelic-induced psychosis: A systematic review
Sulstarova A, Scheuerlein L, Monari S, Seragnoli F, Gabriel T, Preller K, Böge K, Sentissi O, Kaiser S, Solmi M, Kirschner M, Sabé M. Treatment approaches and efficacy in psychedelic-induced psychosis: A systematic review. Asian Journal Of Psychiatry 2025, 110: 104604. PMID: 40614615, DOI: 10.1016/j.ajp.2025.104604.Peer-Reviewed Original ResearchConceptsFirst-generation antipsychoticsSecond-generation antipsychoticsElectroconvulsive therapySchizophrenia spectrum disordersRisk of psychosisSecond-generation agentsCase seriesCase reportFollow-upBipolar disorderAntipsychoticsMinority of usersPsychosisSpectrum disorderAverage patient agePrimary substanceFollow-up dataSystematic reviewInterpretation of findingsComprehensive follow-upTreatment approachesSecond-generationPatient ageProspective studyTreatment optionsA Consensus Taxonomy of Altered (Nonordinary) States of Consciousness: Bringing Order to Disarray
Cardeña E, Berkovich-Ohana A, Valli K, Barttfeld P, Gomez-Marin A, Greyson B, Kumar V, Laureys S, Luhrmann T, Newberg A, Preller K, Putnam F, Tagliazucchi E, Walsh R, Carter O, Yaden D. A Consensus Taxonomy of Altered (Nonordinary) States of Consciousness: Bringing Order to Disarray. Psychology Of Consciousness Theory Research And Practice 2025 DOI: 10.1037/cns0000431.Peer-Reviewed Original ResearchNeurocognitive effects of psilocybin: A systematic and comprehensive review of neuroimaging studies in humans
Berkovitch L, Fauvel B, Preller K, Gaillard R. Neurocognitive effects of psilocybin: A systematic and comprehensive review of neuroimaging studies in humans. Neuroscience & Biobehavioral Reviews 2025, 175: 106239. PMID: 40456393, DOI: 10.1016/j.neubiorev.2025.106239.Peer-Reviewed Original ResearchConceptsEffects of psilocybinPsilocybin effectsNeuroimaging studiesBrain changesNeuroimaging techniquesTherapeutic effects of psilocybinTreat various psychiatric disordersFunctional brain changesSamples of healthy volunteersSerotonergic compoundsEmotional processingNeurobiological mechanismsMode networkPsychiatric disordersCognitive tasksPsychoactive effectsBrain activityNeuroimaging dataPsilocybinSelf-experienceAssociated with acute alterationsSocial functioningTherapeutic effectBrainNeuronal networksPictorial representation of illness and self measure (PRISM): A putative transdiagnostic tool for evaluating therapeutic effects of psychedelic treatments
Pouyan N, Aday J, Harte S, Kaplan C, Williams D, Glynos N, Herberholz M, Kruger D, Barron J, Mashour G, Clauw D, Preller K, Schrepf A, Boehnke K. Pictorial representation of illness and self measure (PRISM): A putative transdiagnostic tool for evaluating therapeutic effects of psychedelic treatments. Journal Of Psychopharmacology 2025, 39: 489-498. PMID: 40323119, DOI: 10.1177/02698811251330763.Peer-Reviewed Original ResearchConceptsNaturalistic psychedelic usePsychedelic useSymptom changeSymptom improvementAssociated with symptom improvementEffects of psychedelicsPosttraumatic stress disorderIndividual perceptions of selfPerceptions of selfPRISM scoreRepresentations of illnessPsychedelic treatmentStress disorderGlobal ImpressionPsychedelic experiencePictorial representationPictorial Representation of IllnessRetrospective reportsSelf-PerceptionReduced identificationChange scoresRetrospectively assessed changesPGIC scoresPatient Global ImpressionConvenience sample481. Resting-State Perfusion and Executive Control Task Performance in Psychosis Spectrum Disorder
Cail C, Rahmati M, Fonteneau C, Zharyy C, Forselius-Bielen K, Beri E, Miller E, Santamauro N, Anticevic A, Cortes-Briones J, Proulx E, Preller K, Cho Y. 481. Resting-State Perfusion and Executive Control Task Performance in Psychosis Spectrum Disorder. Biological Psychiatry 2025, 97: s295-s296. DOI: 10.1016/j.biopsych.2025.02.719.Peer-Reviewed Original Research533. Bold Signal Can Capture Individual Variability in Spatial Working Memory Deficits Induced by Ketamine
Rahmati M, Moujaes F, Purg N, Fonteneau C, Santamauro N, Tamayo Z, Repovs G, Preller K, Anticevic A, Fineberg S, Murray J, Krystal J, Cho Y. 533. Bold Signal Can Capture Individual Variability in Spatial Working Memory Deficits Induced by Ketamine. Biological Psychiatry 2025, 97: s317. DOI: 10.1016/j.biopsych.2025.02.772.Peer-Reviewed Original Research